MediWound (MDWD) Tops Q3 EPS by 1c

Go back to MediWound (MDWD) Tops Q3 EPS by 1c

MediWound Reports Third Quarter 2021 Financial Results

November 16, 2021 7:00 AM EST

Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21%

Clarity on Regulatory Pathway for Resubmission of NexoBrid BLA, Anticipated in Mid- 2022

EscharEx Phase 2 Program Top-Line Results Accelerated, Currently Expected in the First Quarter of 2022

Conference call begins today at 8:30 am ET

YAVNE, Israel, Nov. 16, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the Company), a fully-integrated... More